Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6,299.10%57.02M | 2,268.29%54.52M | 266.73%15.45M | 36.05%-22.62M | -954.68%-16.55M | 26.56%891K | 114.51%2.3M | 50.30%-9.27M | -643.02%-35.38M | 64.69%-1.57M |
| Non interest income | 6,299.10%57.02M | 2,268.29%54.52M | 266.73%15.45M | 36.05%-22.62M | -954.68%-16.55M | 26.56%891K | 114.51%2.3M | 50.30%-9.27M | -643.02%-35.38M | 64.69%-1.57M |
| -Fees and commissions | -169.02%-495K | -81.01%-286K | -68.18%-222K | -16.19%-689K | -58.09%-215K | -28.67%-184K | -0.64%-158K | 15.92%-132K | 21.04%-593K | 21.84%-136K |
| Credit losses provision | ||||||||||
| Non interest expense | ||||||||||
| Selling and administrative expenses | 82.63%305K | 33.94%221K | 37.97%218K | 21.69%634K | 42.57%144K | 20.14%167K | 17.86%165K | 12.06%158K | -4.93%521K | -7.34%101K |
| -General and administrative expense | 82.63%305K | 33.94%221K | 37.97%218K | 21.69%634K | 42.57%144K | 20.14%167K | 17.86%165K | 12.06%158K | -4.93%521K | -7.34%101K |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 7,949.01%56.67M | 2,460.92%54.27M | 261.07%15.21M | 35.26%-23.34M | -841.86%-16.72M | 28.00%704K | 113.23%2.12M | 49.79%-9.44M | -573.31%-36.05M | 61.00%-1.78M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 7,949.01%56.67M | 2,460.92%54.27M | 261.07%15.21M | 35.26%-23.34M | -841.86%-16.72M | 28.00%704K | 113.23%2.12M | 49.79%-9.44M | -573.31%-36.05M | 61.00%-1.78M |
| Net Income continuous operations | 7,949.01%56.67M | 2,460.92%54.27M | 261.07%15.21M | 35.26%-23.34M | -841.86%-16.72M | 28.00%704K | 113.23%2.12M | 49.79%-9.44M | -573.31%-36.05M | 61.00%-1.78M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 7,949.01%56.67M | 2,460.92%54.27M | 261.07%15.21M | 35.26%-23.34M | -841.86%-16.72M | 28.00%704K | 113.23%2.12M | 49.79%-9.44M | -573.31%-36.05M | 61.00%-1.78M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 7,949.01%56.67M | 2,460.92%54.27M | 261.07%15.21M | 35.26%-23.34M | -841.86%-16.72M | 28.00%704K | 113.23%2.12M | 49.79%-9.44M | -573.31%-36.05M | 61.00%-1.78M |
| Diluted earnings per share | 3,500.00%1.8 | 1,335.29%2.44 | 194.19%0.81 | 52.69%-1.67 | -945.45%-1.15 | 0.00%0.05 | 110.63%0.17 | 55.44%-0.86 | -553.70%-3.53 | 76.09%-0.11 |
| Basic earnings per share | 3,500.00%1.8 | 1,335.29%2.44 | 194.19%0.81 | 52.69%-1.67 | -604.41%-1.15 | 0.00%0.05 | 110.63%0.17 | 55.44%-0.86 | -553.70%-3.53 | 65.48%-0.1633 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.